Utilizing Nuclear Medicine Imaging Techniques in Preclinical Animal Models to Achieve the “3R” Concepts
DOI:
https://doi.org/10.48165/jlas.2025.8.2.3Keywords:
3Rs, Rabbit, PET-CT, Scintigraphy imaging study, BiodistributionAbstract
Laboratory animals are the most widely established species in numerous fields for studying and developing new drug molecules and toxicity testing. A disproportionate number of animals are euthanized in the drug development and research field for societal benefit. In order to reduce the number of laboratory animals, a precise in vivo assessment system is essential to obtain statistically significant data. The project was initiated to evaluate vital organ function by utilizing nuclear medicine imaging techniques and radiopharmaceuticals. In this study, six mature rabbits (8-9 months old) of both sexes were systematically evaluated for vital organs like the brain, thyroid gland, salivary gland, heart, lung, liver, kidney function, skeletal system, and lymphatic system using organ-specific radiopharmaceuticals with scintigraphy and PET-CT imaging techniques. A detailed assessment of the function of each organ in rabbits was undertaken. No abnormalities were observed in the study animals under investigation. The uptake and clearance pattern of radiopharmaceuticals determined the normal organ function of rabbits and was found to be comparable with humans. In vivo, analysis with data generation was conceivable without sacrificing animals. Henceforth, by applying the 3Rs principle, the reduction and refine procedure is accomplished with a significant amount of critical data generated against each time point. Therefore, applying imaging techniques with the “3RS” principle proves to be an efficient method for rational use of laboratory animals during the investigation.
Downloads
References
1. Mukherjee, P., Roy, S., Ghosh, D., & Nandi, S. K. (2022). Role of animal models in biomedical research: A review. Laboratory Animal Research, 38(1), 18.
2. Rai, J., & Kaushik, K. (2018). Reduction of animal sacrifice in biomedical science & research through alternative design of animal experiments. Saudi Pharmaceutical Journal, 26(6), 896–902.
3. Sneddon, L. U., Halsey, L. G., & Bury, N. R. (2017). Considering aspects of the 3Rs principles within experimental animal biology. Journal of Experimental Biology, 220(17), 3007–3016.
4. CPCSEA. (2018). Guidelines Compendium. India, pp. 1–202.
5. OECD (Organisation for Economic Co-operation and Development). (2000). Guidance document on recognizing, assessing, and using clinical signs as humane endpoints for experimental animals used in safety evaluation (ENV/JM/MONO(2000)7).
6. OECD. (2018). Test No. 433: Acute Inhalation Toxicity: Fixed Concentration Procedure.
7. OECD. (1995). OECD Guideline for the Testing of Chemicals: Repeated Dose 28-Day Oral Toxicity Study in Rodents.
8. Koziorowski, J., Behe, M., Decristoforo, C., Ballinger, J., Elsinga, P., & Ferrari, V. (2017). Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals. EJNMMI Radiopharmacy and Chemistry, 1, 1–6.
9. Schwarz, S., & Decristoforo, C. (2019). US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations. EJNMMI Radiopharmacy and Chemistry, 4, 1–5.
10. Taylor, K., Gordon, N., Langley, G., & Higgins, W. (2008). Estimates for worldwide laboratory animal use in 2005. Alternatives to Laboratory Animals, 36(3), 327–342.
11. Van Norman, G. A. (2020). Limitations of animal studies for predicting toxicity in clinical trials: Part 2: Potential alternatives to the use of animals in preclinical trials. Basic and Translational Science, 5(4), 387–397.
12. Epstein, Y., & Leshem, M. (2002). Animal experimentation in Israel. Harefuah, 141(4), 358–361.
13. Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2024). Replacing animal testing with stem cell-organoids: Advantages and limitations. Stem Cell Reviews and Reports, 20(6), 1375–1386.
14. Shanks, N., & Green, K. (2004). Evolution and the ethics of animal research. Essays in Philosophy, 5(2), 455–473.
15. Daneshian, M., Busquet, F., Hartung, T., & Leist, M. (2015). Animal use for science in Europe. Altex, 32(24), 261–274.
16. Sneddon, J., & Rollin, B. (2010). Mulesing and animal ethics. Journal of Agricultural and Environmental Ethics, 23, 371–386.
17. Yitbarek, D., & Dagnaw, G. (2022). Application of advanced imaging modalities in veterinary medicine: A review. Veterinary Medicine (Auckland), 13, 117–130.
18. Pawar, Y., Bhartiya, U., Rakshit, S., Nandy, S., Lakshminarayanan, N., & Banerjee, S. (2019). Diagnosis of pathological conditions in laboratory animals by using advance nuclear medicine imaging techniques. Indian Journal of Veterinary Pathology, 43(2), 109–114.
19. Saha, G. B. (2004). Diagnostic uses of radiopharmaceuticals in nuclear medicine. In Fundamentals of Nuclear Pharmacy (5th ed., pp. 247–329). Springer.
20. Subtirelu, R. C., Teichner, E. M., Su, Y., Al-Daoud, O., Patel, M., & Patil, S. (2023). Aging and cerebral glucose metabolism: 18F-FDG-PET/CT reveals distinct global and regional metabolic changes in healthy patients. Life (Basel), 13(10), 2044.
21. Tremoleda, J. (2022). Reducing the number of research animals: How imaging technologies can help. Frontiers for Young Minds, 10, 953662.
22. Wu, S. Y., Kuo, J. W., Chang, T. K., Liu, R. S., Lee, R. C., & Wang, S. J. (2012). Preclinical characterization of 18F-MAA, a novel PET surrogate of 99mTc-MAA. Nuclear Medicine and Biology, 39(7), 1026–1033.
23. Silberstein, E., & Ryan, J. (1996). Prevalence of adverse reactions in nuclear medicine. Journal of Nuclear Medicine, 37(1), 185–192.
24. Vanaja, R., Pandey, P., & Ramamurthy, N. (2000). Technetium 99m Radiopharmaceuticals. In Radiopharmaceuticals and Hospital Radiopharmacy Practices (pp. 11–27). BRIT, DAE, Mumbai.
25. Meyer-Lindenberg, A., Westhoff, A., Wohlsein, P., & Nolte, I. (1996). Validity of diagnostic methods for kidney function tests in the cat. Tierärztliche Praxis, 24(4), 395–401.
26. Kintzer, P. P., & Peterson, M. E. (1994). Nuclear medicine of the thyroid gland. Scintigraphy and radioiodine therapy. Veterinary Clinics of North America: Small Animal Practice, 24(3), 587–605.
27. Pawar, Y., Bhartiya, U., Joseph, L., & Singh, D. (2021). Simulation of rabbit model to study the effect of 131Iodine and radioprotectant on salivary gland ultrastructure. Indian Journal of Veterinary Pathology, 45(3), 221–224.
28. Ergun, E., Bozkurt, M., Ercan, M., Ruacan, S., Sener, B., & Ünsal, I. (2002). Detection of inflammatory lymph nodes in rabbits by 99mTc-HIG lymphoscintigraphy. Nuclear Medicine Communications, 23(12), 1177–1182.
29. Beck, K., Horn, W., & Feldman, E. (1985). The normal feline thyroid: Technetium pertechnetate imaging and determination of thyroid to salivary gland radioactivity ratios in 10 normal cats. Veterinary Radiology, 26, 35.
30. Peremans, K., Vermeire, S., Dobbeleir, A., Gielen, I., Samoy, Y., & Piron, K. (2011). Recognition of anatomical predilection sites in canine elbow pathology on bone scans using micro-single photon emission tomography. Veterinary Journal, 188(1), 64–72.
